Danaher Co. (NYSE:DHR) Shares Sold by AMG National Trust Bank

AMG National Trust Bank lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 24.4% in the third quarter, Holdings Channel.com reports. The firm owned 20,534 shares of the conglomerate’s stock after selling 6,618 shares during the period. AMG National Trust Bank’s holdings in Danaher were worth $5,708,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of DHR. CarsonAllaria Wealth Management Ltd. bought a new position in Danaher during the 2nd quarter worth approximately $25,000. nVerses Capital LLC bought a new stake in Danaher in the 2nd quarter valued at about $25,000. MFA Wealth Advisors LLC acquired a new position in Danaher during the 2nd quarter valued at about $51,000. Financial Connections Group Inc. bought a new position in Danaher in the 2nd quarter worth about $51,000. Finally, Western Pacific Wealth Management LP bought a new stake in shares of Danaher during the first quarter valued at approximately $55,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is owned by company insiders.

Danaher Stock Down 3.7 %

Shares of Danaher stock opened at $230.50 on Monday. The stock has a 50-day simple moving average of $262.20 and a 200-day simple moving average of $260.57. Danaher Co. has a 52-week low of $206.30 and a 52-week high of $281.70. The firm has a market cap of $166.48 billion, a price-to-earnings ratio of 43.99, a P/E/G ratio of 4.24 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.02 earnings per share. On average, equities research analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s dividend payout ratio is 20.61%.

Analysts Set New Price Targets

Several analysts recently commented on DHR shares. Raymond James lowered their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI increased their target price on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Stephens restated an “overweight” rating and set a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. Leerink Partners raised their target price on shares of Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Finally, Stifel Nicolaus upped their price target on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.